Literature DB >> 9452291

Seroprevalence of lymphocytic choriomeningitis virus in Nova Scotia.

T J Marrie1, M F Saron.   

Abstract

An ELISA system was used to determine the rate of seropositivity to lymphocytic choriomeningitis virus (LCMV) among a random sample of 505 Nova Scotians. Twenty (4%) were positive. Complete questionnaire data were available on all 20 seropositive subjects and on 449 seronegative subjects. Seventeen (85%) of the seropositive subjects were females (P = 0.03). It is concluded that infection with LCMV is present in Nova Scotia and females are more likely to be infected than males.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9452291     DOI： 10.4269/ajtmh.1998.58.47

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  7 in total

1.  Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.

Authors:  Lukas Flatz; Cheng Cheng; Lingshu Wang; Kathryn E Foulds; Sung-Youl Ko; Wing-Pui Kong; Rahul Roychoudhuri; Wei Shi; Saran Bao; John-Paul Todd; Mohammed Asmal; Ling Shen; Mitzi Donaldson; Stephen D Schmidt; Jason G D Gall; Daniel D Pinschewer; Norman L Letvin; Srinivas Rao; John R Mascola; Mario Roederer; Gary J Nabel
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Authors:  Hong D Chen; Armando E Fraire; Isabelle Joris; Raymond M Welsh; Liisa K Selin
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.

Authors:  Martin S Zinkernagel; Beatrice Bolinger; Philippe Krebs; Lucas Onder; Simone Miller; Burkhard Ludewig
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

5.  Prevalence and Risk Factors for Lymphocytic Choriomeningitis Virus Infection in Continental Croatian Regions.

Authors:  Tatjana Vilibic-Cavlek; Tena Oreski; Misa Korva; Branko Kolaric; Vladimir Stevanovic; Snjezana Zidovec-Lepej; Irena Tabain; Pavle Jelicic; Bozana Miklausic-Pavic; Vladimir Savic; Ljubo Barbic; Tatjana Avsic-Zupanc
Journal:  Trop Med Infect Dis       Date:  2021-04-29

Review 6.  Lymphocytic Choriomeningitis-Emerging Trends of a Neglected Virus: A Narrative Review.

Authors:  Tatjana Vilibic-Cavlek; Vladimir Savic; Thomas Ferenc; Anna Mrzljak; Ljubo Barbic; Maja Bogdanic; Vladimir Stevanovic; Irena Tabain; Ivana Ferencak; Snjezana Zidovec-Lepej
Journal:  Trop Med Infect Dis       Date:  2021-05-25

7.  Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV.

Authors:  Kathryn M Hastie; Sébastien Igonet; Brian M Sullivan; Pierre Legrand; Michelle A Zandonatti; James E Robinson; Robert F Garry; Félix A Rey; Michael B Oldstone; Erica Ollmann Saphire
Journal:  Nat Struct Mol Biol       Date:  2016-04-25       Impact factor: 15.369
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.